Skip to main content
. 2025 Feb 11;9(2):102702. doi: 10.1016/j.rpth.2025.102702

Figure 1.

Figure 1

The stepwise protocol design. HD-DXM, high-dose dexamethasone; i.v., intravenously; NR, no response; RTX, rituximab; TPO-RA, thrombopoietin receptor agonist.